Physician profile
Sharon D Warner
NPI 1417008871
$849.64
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $347 · 2021: $32.78.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $187.93 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $134.72 | 2019 | |
| Kyowa Kirin, INC. | $117.54 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.13 | 2019-2020 | |
| Philips North America LLC | $56.32 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $42.83 | 2019 | |
| Glaxosmithkline, LLC. | $32.78 | 2021 | |
| Mannkind Corporation | $28.80 | 2019 | |
| Amarin Pharma, INC. | $28.16 | 2020 | |
| Collegium Pharmaceutical, INC. | $27.91 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $25.73 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $14.88 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.80 | 2019 | |
| Allergan, INC. | $13.55 | 2019 | |
| Eisai INC. | $12.56 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.